Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
IPO Year:
Exchange: NASDAQ
Website: optioncarehealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/30/2025 | $40.00 | Neutral → Buy | UBS |
| 1/23/2025 | $26.00 → $35.00 | Hold → Buy | Jefferies |
| 1/13/2025 | $26.00 → $33.00 | Neutral → Buy | BofA Securities |
| 12/5/2024 | $26.00 | Neutral | UBS |
| 11/4/2024 | $27.00 | Buy → Neutral | Goldman |
| 10/31/2024 | $38.00 → $26.00 | Buy → Hold | Jefferies |
| 10/30/2024 | $43.00 → $29.00 | Buy → Neutral | BofA Securities |
| 7/16/2024 | $36.00 | Mkt Outperform | JMP Securities |
| 2/27/2023 | $38.00 | Buy | Jefferies |
| 8/4/2021 | $22.00 → $24.00 | Buy | Canaccord Genuity |
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
UBS upgraded Option Care Health from Neutral to Buy and set a new price target of $40.00
Jefferies upgraded Option Care Health from Hold to Buy and set a new price target of $35.00 from $26.00 previously
BofA Securities upgraded Option Care Health from Neutral to Buy and set a new price target of $33.00 from $26.00 previously
UBS initiated coverage of Option Care Health with a rating of Neutral and set a new price target of $26.00
Goldman downgraded Option Care Health from Buy to Neutral and set a new price target of $27.00
Jefferies downgraded Option Care Health from Buy to Hold and set a new price target of $26.00 from $38.00 previously
BofA Securities downgraded Option Care Health from Buy to Neutral and set a new price target of $29.00 from $43.00 previously
JMP Securities initiated coverage of Option Care Health with a rating of Mkt Outperform and set a new price target of $36.00
Jefferies resumed coverage of Option Care Health with a rating of Buy and set a new price target of $38.00
Canaccord Genuity reiterated coverage of Option Care Health with a rating of Buy and set a new price target of $24.00 from $22.00 previously
8-K - Option Care Health, Inc. (0001014739) (Filer)
10-Q - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
DEFA14A - Option Care Health, Inc. (0001014739) (Filer)
DEF 14A - Option Care Health, Inc. (0001014739) (Filer)
PRE 14A - Option Care Health, Inc. (0001014739) (Filer)
10-K - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
SCHEDULE 13G/A - Option Care Health, Inc. (0001014739) (Subject)
BANNOCKBURN, Ill., June 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2025 on Wednesday, July 30, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI6761a41f2d314134ba5d574509278b8d. The call can also be accessed via a liv
BANNOCKBURN, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: The Bank of America Healthcare Conference, being held in Las Vegas, on Tuesday, May 13, 2025, including a presentation at 8:00am PT/11:00am ET.The William Blair 45th Annual Growth Stock Conference, being held in Chicago, on Tuesday, June 3, 2025, including a presentation at 11:20am CT/12:20pm ET.The Goldman Sachs 46th Annual Global Healthcare Conference, being held in Miami, on Monday, June 9, 2025, including a fireside chat
BANNOCKBURN, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenue of $1,333.0 million, up 16.3% compared to $1,146.1 million in the first quarter of 2024Gross profit of $263.1 million, or 19.7% of net revenue, up 10.3% compared to $238.5 million, or 20.8% of net revenue, in the first quarter of 2024Net income of $46.7 million, compared to net income of $44.8 million, in the first quarter of 2024 and diluted
BANNOCKBURN, Ill., March 24, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2025 on Tuesday, April 29, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI29e3b2a044544585b1ab833b09a90572. The call can also be accessed via a liv
BANNOCKBURN, Ill., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Net revenue of $1,346.4 million, up 19.7% compared to $1,124.4 million in the fourth quarter of 2023Gross profit of $268.4 million, or 19.9% of net revenue, up 8.6% compared to $247.1 million, or 22.0% of net revenue, in the fourth quarter of 2023Net income of $60.1 million, compared to net income of $57.2 million, in the fourth quarter
BANNOCKBURN, Ill., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2024. For the fourth quarter 2024, Option Care Health expects to report: Net revenue of approximately $1.34 billion to $1.35 billion, representing approximately 19.2% to 20.1% growth over the fourth quarter of 2023Net income of approximately $56.8 to $60.9 million, or diluted earnings per share of $0.33 to $0.36Adjusted net income of approximately $71.0 million
BANNOCKBURN, Ill., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, will participate in the 43rd Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Monday, January 13, 2025, including a presentation at 1:30pm PT. The webcast and related presentation materials will be available online at https://investors.optioncarehealth.com. About Option Care Health Option Care Health is the nation's largest independent provider of home and alternate site infusion services. With over 7,500 team members including more than 4,500 clinicians, we work
BANNOCKBURN, Ill., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference, being held in London, on Tuesday, November 19, 2024, including a fireside chat at 8:30am GMT/3:30am ET.Bank of America Leveraged Finance Conference, being held in Boca Raton, FL, on Tuesday, December 3, 2024, including a presentation at 8:50am ET.Bank of America Home Care Conference, being held virtually, on Monday, December 9, 2024, including a fireside chat at 11:10am ET. Webcast li
BANNOCKBURN, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Results and Highlights Net revenue of $1,278.5 million, up 17.0% compared to $1,093.0 million in the third quarter of 2023Gross profit of $256.7 million, or 20.1% of net revenue, up 1.0% compared to $254.3 million, or 23.3% of net revenue, in the third quarter of 2023Net income of $53.9 million, or $0.31 diluted earnings per share, down 4.3% compared to net inco
BANNOCKBURN, Ill., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2024 on Wednesday, October 30, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details Participants can pre-register for the conference call at the following link: https://register.vevent.com/register/BI08e5c12fc6d744c2bb159e0e3b1ebbc4. The call can also be accessed via a live
NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, today announced the appointment of Barbara W. Bodem and David Keeling to its Board of Managers, effective February 12, 2024. Following these appointments, the Board will comprise of 8 directors, 5 of whom are non-executive. "We are pleased to welcome Barbara and David to the NorthStar Board," said Stephen Merrick, Executive Chairman of NorthStar. "Barbara's deep experience serving in senior finance and board roles in leading edge pharmaceutical and
New Board Brings Significant and Diverse Experience to Support Company's Growth and Success Riverbed|Aternity (the "Company") today announced that, as part of its recapitalization, which was finalized today, the following seven directors have been appointed to the Company's new Board of Directors (the "Board"). These appointments became effective on December 7, 2021, upon the completion of the Company's recapitalization and voluntary court-supervised process. "We are pleased to welcome our new directors, a group of seasoned, accomplished and respected business leaders who will bring a wide and diverse range of skills to the Riverbed|Aternity Board," said Dan Smoot, President and CEO of Ri
BANNOCKBURN, Ill., July 28, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health")(NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today that Dr. Seema Kumbhat has joined the Company as Chief Medical Officer. In this newly created role, Dr. Kumbhat will oversee all clinical strategies for the Company, including clinical operations, continuous quality improvement, accreditation, clinically related sales and marketing efforts, and adherence to regulatory requirements. Dr. Kumbhat will also focus on optimizing clinical operations to ensure the Company delivers the highest quality standards, supe
SC 13G - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G/A - Option Care Health, Inc. (0001014739) (Subject)
SC 13G - Option Care Health, Inc. (0001014739) (Subject)
SC 13G - Option Care Health, Inc. (0001014739) (Subject)
BANNOCKBURN, Ill., June 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2025 on Wednesday, July 30, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI6761a41f2d314134ba5d574509278b8d. The call can also be accessed via a liv
BANNOCKBURN, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Net revenue of $1,333.0 million, up 16.3% compared to $1,146.1 million in the first quarter of 2024Gross profit of $263.1 million, or 19.7% of net revenue, up 10.3% compared to $238.5 million, or 20.8% of net revenue, in the first quarter of 2024Net income of $46.7 million, compared to net income of $44.8 million, in the first quarter of 2024 and diluted
BANNOCKBURN, Ill., March 24, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2025 on Tuesday, April 29, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call DetailsParticipants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI29e3b2a044544585b1ab833b09a90572. The call can also be accessed via a liv
BANNOCKBURN, Ill., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Net revenue of $1,346.4 million, up 19.7% compared to $1,124.4 million in the fourth quarter of 2023Gross profit of $268.4 million, or 19.9% of net revenue, up 8.6% compared to $247.1 million, or 22.0% of net revenue, in the fourth quarter of 2023Net income of $60.1 million, compared to net income of $57.2 million, in the fourth quarter
BANNOCKBURN, Ill., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2024. For the fourth quarter 2024, Option Care Health expects to report: Net revenue of approximately $1.34 billion to $1.35 billion, representing approximately 19.2% to 20.1% growth over the fourth quarter of 2023Net income of approximately $56.8 to $60.9 million, or diluted earnings per share of $0.33 to $0.36Adjusted net income of approximately $71.0 million
BANNOCKBURN, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Results and Highlights Net revenue of $1,278.5 million, up 17.0% compared to $1,093.0 million in the third quarter of 2023Gross profit of $256.7 million, or 20.1% of net revenue, up 1.0% compared to $254.3 million, or 23.3% of net revenue, in the third quarter of 2023Net income of $53.9 million, or $0.31 diluted earnings per share, down 4.3% compared to net inco
BANNOCKBURN, Ill., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2024 on Wednesday, October 30, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details Participants can pre-register for the conference call at the following link: https://register.vevent.com/register/BI08e5c12fc6d744c2bb159e0e3b1ebbc4. The call can also be accessed via a live
BANNOCKBURN, Ill., July 31, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Results and Highlights Net revenue of $1,227.2 million, up 14.8% compared to $1,069.1 million in the second quarter of 2023Gross profit of $249.4 million, or 20.3% of net revenue, down 0.6% compared to $250.8 million, or 23.5% of net revenue, in the second quarter of 2023Net income of $53.0 million, or $0.30 diluted earnings per share, down 53.6% compared to ne
BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2024 on Wednesday, July 31, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details Participants can pre-register for the conference call at the following link: https://register.vevent.com/register/BId5e0db240b9c416cbbdba9d2afe4b745. The call can also be accessed via a live audio w
BANNOCKBURN, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (NASDAQ:OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results and Highlights Net revenue of $1,146.1 million, up 12.8% compared to $1,015.8 million in the first quarter of 2023Gross profit of $238.5 million, or 20.8% of net revenue, up 4.1% compared to $229.0 million, or 22.5% of net revenue, in the first quarter of 2023Net income of $44.8 million, or $0.26 earnings per share, up 14.2% compared to net income of $39.2